Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.35 EUR | -0.87% | +0.13% | -18.67% |
Apr. 30 | Bayer: strategic collaboration with Evotec | CF |
Apr. 30 | Evotec, Bayer to Collaborate on New Cardiovascular Disease Therapies | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
12,062 GBX | +0.32% | +7.22% | 234B | ||
902.6 DKK | +2.01% | +3.12% | 567B | ||
220.6 CHF | -0.27% | -2.30% | 196B | ||
89.05 CHF | +0.20% | +1.93% | 199B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.67% | 29.04B | |
+34.00% | 664B | |
+29.29% | 567B | |
-7.75% | 354B | |
+18.53% | 330B | |
+4.95% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.89% | 148B |
- Stock Market
- Equities
- BAYN Stock
- News Bayer AG
- Bayer : Beset by copies, Roche gets sales boost from China